---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-275721"
form_type: "8-K"
ticker: "INO"
cik: "0001055726"
company_name: "INOVIO PHARMACEUTICALS, INC."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T20:52:19.258825+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Inovio prices 15.1M share offering at $1.90, net proceeds ~$26.5M

## Summary
- Inovio sold 13.158M shares at $1.90; underwriters exercised option for 1.974M additional shares.
- Net proceeds expected ~$26.5M after discounts and expenses; closing November 12, 2025.
- Piper Sandler & Co. acted as sole book-running manager for the offering.
- Offering made under effective shelf registration statement; all shares sold by Inovio.

## SEC filing metadata
- accession: 0001193125-25-275721
- form_type: 8-K
- ticker: INO
- cik: 0001055726
- company_name: INOVIO PHARMACEUTICALS, INC.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1055726/000119312525275721/0001193125-25-275721-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1055726/000119312525275721/d80000d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-275721
- JSON: https://secwatch.observer/filing/0001193125-25-275721.json
- Plain text: https://secwatch.observer/filing/0001193125-25-275721.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.